Target intelligence / Profile preview

Candida tropicalis cell membrane

Molecular classification
Other (Eukaryotic lipid bilayer structure), Transporter, Enzyme, Channel, Sterol (ergosterol)
01

Overview

The Candida tropicalis cell membrane is a lipid bilayer that surrounds the cytoplasm of this pathogenic yeast, composed primarily of phospholipids, proteins, and sterols (notably ergosterol). The membrane is essential for integrity, compartmentalization, transport, signaling, and interaction with host and environmental factors. It is the main interface for antifungal drugs such as azoles and polyenes, which target ergosterol synthesis (azoles) or bind ergosterol to disrupt membrane structure (polyenes). Resistance can arise through changes in sterol composition, overexpression of drug-efflux transporters, and increased membrane fluidity. The cell membrane also mediates interaction with host immunity and plays a role in pathogenicity and biofilm formation. Note: For any structured database, it is recommended to specify the molecular target (e.g., "Ergosterol synthase" or "Drug efflux transporter CDR1") rather than the whole membrane, as the "cell membrane" encompasses a diverse range of molecular entities.

Other names
C. tropicalis plasma membraneC. tropicalis cytoplasmic membrane
02

Mechanism of action

Inhibition of ergosterol synthesis (by azoles, via ERG11); Binding to ergosterol causing membrane disruption (by polyenes); Increased membrane permeability and fluidity (by certain peptides and resistance mutations); Efflux pump–mediated drug export (ABC transporters, major facilitator superfamily).

03

Biological functions

Structural barrier and compartmentalizationTransport of ions and small moleculesSignal transductionDrug efflux and resistanceMembrane potential maintenance
04

Disease associations

Infection (fungal infection in humans)Antifungal drug resistanceVirulence
05

Safety considerations

Host toxicity of membrane-targeting drugs (e.g., amphotericin B binds ergosterol, but also has affinity for cholesterol in human cell membranes, causing nephrotoxicity)Drug resistance via efflux and membrane composition changesStrain-specific variability in membrane composition affecting drug efficacy
06

Interacting drugs

Azoles (e.g., fluconazole, voriconazole: target ergosterol biosynthesis)

3 more in the full profile.

07

Biomarkers

ERG11 mutations (for azole resistance)Overexpression of CDR1, CDR2, CDR3, MDR1 genes (for multidrug resistance)Changes in membrane fluidity (a surrogate for resistance phenotype)

Beyond the preview

Go deeper on Candida tropicalis cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida tropicalis cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call